| 1 | CMTM3, MDFI, SSTR2
|
| Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer.
|
| Patnaik S, Anupriya.
|
| Front Pharmacol 10:588. doi: 10.3389/fphar.2019.00588. eCollection 2019. Review.
2019
|
| 2 | CDH5, CMTM3
|
| CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
|
| Chrifi I, Louzao-Martinez L, Brandt M, van Dijk CGM, Burgisser P, Zhu C, Kros JM, Duncker DJ, Cheng C.
|
| Arterioscler Thromb Vasc Biol 37(6):1098-1114. doi: 10.1161/ATVBAHA.116.308792. Epub 2017 Apr 20.
2017
|
| 3 | CMTM3, MDFI, SSTR2
|
| DNA methylation of CMTM3, SSTR2, and MDFI genes in colorectal cancer.
|
| Li J, Chen C, Bi X, Zhou C, Huang T, Ni C, Yang P, Chen S, Ye M, Duan S.
|
| Gene 630:1-7. doi: 10.1016/j.gene.2017.07.082. Epub 2017 Aug 4.
2017
|
| 4 | CMTM3
|
| Chemokine-like factor-like MARVEL transmembrane domain-containing 3 expression is associated with a favorable prognosis in esophageal squamous cell carcinoma.
|
| Han T, Shu T, Dong S, Li P, Li W, Liu D, Qi R, Zhang S, Zhang L.
|
| Oncol Lett 13(5):2982-2988. doi: 10.3892/ol.2017.5837. Epub 2017 Mar 10.
2017
|
| 5 | CMTM3
|
| Elevated methylation of CMTM3 promoter in the male laryngeal squamous cell carcinoma patients.
|
| Shen Z, Chen X, Li Q, Zhou C, Xu Y, Yu R, Ye H, Li J, Duan S.
|
| Clin Biochem 49(16-17):1278-1282. doi: 10.1016/j.clinbiochem.2016.08.002. Epub 2016 Aug 10.
2016
|
| 6 | CMTM3
|
| CMTM3 presents a secreted form released via exosomes.
|
| Liu B, Li H, Fu W, Cheng Y, Yuan W, Liu W, Xue H, Mo X.
|
| Acta Biochim Biophys Sin (Shanghai) 48(6):584-6. doi: 10.1093/abbs/gmw029. Epub 2016 Apr 28. No abstract available.
2016
|
| 7 | CMTM3
|
| CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.
|
| Hu F, Yuan W, Wang X, Sheng Z, Yuan Y, Qin C, He C, Xu T.
|
| Clin Transl Oncol 17(8):632-9. doi: 10.1007/s12094-015-1288-9. Epub 2015 May 20.
2015
|
| 8 | CMTM3
|
| CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
|
| Zhang H, Zhang J, Nan X, Li X, Qu J, Hong Y, Sun L, Chen Y, Li T.
|
| Tumour Biol 36(10):7849-58. doi: 10.1007/s13277-015-3504-1. Epub 2015 May 7.
2015
|
| 9 | CMTM3
|
| CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancer.
|
| Su Y, Lin Y, Zhang L, Liu B, Yuan W, Mo X, Wang X, Li H, Xing X, Cheng X, Dong B, Hu Y, Du H, Zhu Y, Ding N, Li J, Liu W, Ma Y, Qiu X, Ji J, Han W.
|
| Cancer Sci 105(1):26-34. doi: 10.1111/cas.12304. Epub 2013 Nov 28.
2014
|
| 10 | CMTM3
|
| CMTM3 is frequently reduced in clear cell renal cell carcinoma and exhibits tumor suppressor activities.
|
| Xie J, Yuan Y, Liu Z, Xiao Y, Zhang X, Qin C, Sheng Z, Xu T, Wang X.
|
| Clin Transl Oncol 16(4):402-9. doi: 10.1007/s12094-013-1092-3. Epub 2013 Aug 2.
2014
|
| 11 | CMTM3, KLK3
|
| CMTM3 can affect the transcription activity of androgen receptor and inhibit the expression level of PSA in LNCaP cells.
|
| Wang Y, Li T, Qiu X, Mo X, Zhang Y, Song Q, Ma D, Han W.
|
| Biochem Biophys Res Commun 371(1):54-8. Epub 2008 Apr 8. 2008
|
| 12 | CMTM1, CMTM2, CMTM3, CMTM4, CMTM5, CMTM6, CMTM7, CMTM8
|
| Identification of eight genes encoding chemokine-like factor superfamily members 1-8 (CKLFSF1-8) by in silico cloning and experimental validation.
|
| Han W, Ding P, Xu M, Wang L, Rui M, Shi S, Liu Y, Zheng Y, Chen Y, Yang T, Ma D.
|
| Genomics 81(6):609-17. 2003
|